CS-1036 phase 2 study - dose response study of CS-1036 in patients with type 2 diabetes
Phase 2
- Conditions
- Patients with Type 2 Diabetes
- Registration Number
- JPRN-jRCT2080221087
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients diagnosed with type 2 diabetes mellitus
Exclusion Criteria
- Patient with type 1 diabetes mellitus
- Patient with clinically significant diabetic complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method